Milestone Pharmaceuticals Inc.
Status: Publicly traded
Direct answer
Milestone Pharmaceuticals Inc. is publicly traded on NASDAQ under the ticker MIST.
Milestone Pharmaceuticals Inc. is a biopharmaceutical company based in Montréal, Canada, specializing in the creation and commercialization of cardiovascular therapeutics. Their flagship product, etripamil, an innovative channel blocker, is currently in advanced clinical development. It is undergoing Phase III trials for the treatment of paroxysmal supraventricular tachycardia (PSVT) in the United States and Canada,...
Can you invest in Milestone Pharmaceuticals Inc.?
Yes. Milestone Pharmaceuticals Inc. trades publicly on NASDAQ as MIST.
View deeper analysis
View detailed research on MarketSnap, including financials, valuation tools, and analyst context.
Open research for Milestone Pharmaceuticals Inc.
Detailed equity research is provided by MarketSnap.